Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020
Nir Menachemi, Constantin T. Yiannoutsos, Brian E. Dixon, et al.
MMWR Morbidity and Mortality Weekly Report (2020) Vol. 69, Iss. 29, pp. 960-964
Open Access | Times Cited: 188

Showing 26-50 of 188 citing articles:

Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 59
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020
Preeti Pathela, Addie Crawley, Don Weiss, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 2, pp. 196-206
Open Access | Times Cited: 51
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
Kene David Nwosu, Joseph Fokam, Franck Wanda, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
Elizabeth T. Rogawski McQuade, Kristin A. Guertin, Lea Becker, et al.
JAMA Network Open (2021) Vol. 4, Iss. 2, pp. e2035234-e2035234
Open Access | Times Cited: 49
Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California
Tim A. Bruckner, Daniel M. Parker, Scott M. Bartell, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 47
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
Thomas Vogl, Sigal Leviatan, Eran Segal
Cell Reports Medicine (2021) Vol. 2, Iss. 2, pp. 100191-100191
Open Access | Times Cited: 45
Fundamental Identifiability Limits in Molecular Epidemiology
Stilianos Louca, Angela McLaughlin, Ailene MacPherson, et al.
Molecular Biology and Evolution (2021) Vol. 38, Iss. 9, pp. 4010-4024
Open Access | Times Cited: 44
SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June–July 2020
Cristian Díaz-Vélez, Virgilio E. Failoc‐Rojas, Mario J. Valladares-Garrido, et al.
PeerJ (2021) Vol. 9, pp. e11210-e11210
Open Access | Times Cited: 40
Generating synthetic population for simulating the spatiotemporal dynamics of epidemics
Kemin Zhu, Ling Yin, Kang Liu, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 2, pp. e1011810-e1011810
Open Access | Times Cited: 5
Pulmonary lymphoid tissue induced after SARS-CoV-2 infection in rhesus macaques
Zhong-Min Ma, Katherine J. Olstad, Koen K. A. Van Rompay, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Population‐based prevalence surveys during the Covid‐19 pandemic: A systematic review
Vinícius Bonetti Franceschi, Andressa Schneiders Santos, Andressa Barreto Glaeser, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 4
Open Access | Times Cited: 47
Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response
Aaron J. Siegler, Patrick S. Sullivan, Travis Sanchez, et al.
Annals of Epidemiology (2020) Vol. 49, pp. 50-60
Open Access | Times Cited: 40
Cohort profile: a national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA—the CHASING COVID Cohort study
McKaylee Robertson, Sarah Kulkarni, Madhura S. Rane, et al.
BMJ Open (2021) Vol. 11, Iss. 9, pp. e048778-e048778
Open Access | Times Cited: 38
Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership
David M. Herrington, John W. Sanders, Thomas F. Wierzba, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Impact of a New SARS-CoV-2 Variant on the Population: A Mathematical Modeling Approach
Gilberto González‐Parra, David Martínez‐Rodríguez, R.-J. Villanueva
Mathematical and Computational Applications (2021) Vol. 26, Iss. 2, pp. 25-25
Open Access | Times Cited: 36
Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020
Patrick S. Sullivan, Aaron J. Siegler, Kayoko Shioda, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 7, pp. 1141-1150
Open Access | Times Cited: 36
Using test positivity and reported case rates to estimate state-level COVID-19 prevalence and seroprevalence in the United States
Weihsueh A. Chiu, Martial L. Ndeffo-Mbah
PLoS Computational Biology (2021) Vol. 17, Iss. 9, pp. e1009374-e1009374
Open Access | Times Cited: 36
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
Joseph E. Ebinger, Gregory J. Botwin, Christine M. Albert, et al.
BMJ Open (2021) Vol. 11, Iss. 2, pp. e043584-e043584
Open Access | Times Cited: 35
Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA
Brittany Smith, Andrew B. Janowski, Jonathan E. Danis, et al.
mSphere (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 34
Monitoring epidemics: Lessons from measuring population prevalence of the coronavirus
Samuel J. Clark, Abigail Norris Turner
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 9
Open Access | Times Cited: 34
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez‐Saez, et al.
Scandinavian Journal of Public Health (2021) Vol. 50, Iss. 1, pp. 124-135
Open Access | Times Cited: 34
Impacts of K-12 school reopening on the COVID-19 epidemic in Indiana, USA
Guido España, Sean Cavany, Rachel J. Oidtman, et al.
Epidemics (2021) Vol. 37, pp. 100487-100487
Open Access | Times Cited: 33
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis
Mobin Azami, Yousef Moradi, Asra Moradkhani, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample — Oregon, May 11–June 15, 2020
Melissa Sutton, Paul R. Cieslak, Meghan Linder
MMWR Morbidity and Mortality Weekly Report (2020) Vol. 69, Iss. 32, pp. 1100-1101
Open Access | Times Cited: 38
Infection Fatality Ratios for COVID-19 Among Noninstitutionalized Persons 12 and Older: Results of a Random-Sample Prevalence Study
Justin Blackburn, Constantin T. Yiannoutsos, Aaron E. Carroll, et al.
Annals of Internal Medicine (2020) Vol. 174, Iss. 1, pp. 135-136
Open Access | Times Cited: 38

Scroll to top